Nidocard Retard Tablet 2.6 mg contains Nitroglycerin, a long-acting nitrate used for the prevention and management of angina pectoris (chest pain caused by reduced blood flow to the heart). Unlike immediate-release formulations, this sustained-release (retard) tablet is designed to provide prolonged therapeutic effects, allowing for once- or twice-daily dosing and consistent protection against angina attacks.

Nitroglycerin works by relaxing smooth muscles in blood vessels, especially veins and coronary arteries. This vasodilation reduces the workload on the heart and lowers myocardial oxygen demand, preventing ischemic episodes. The sustained-release design of Nidocard Retard ensures that the drug is gradually absorbed over several hours, providing steady plasma levels and reducing the frequency of angina attacks without the peaks and troughs seen with conventional nitroglycerin tablets.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Nidocard Retard Tablet 2.6 mg is indicated for:

• Chronic stable angina: To prevent recurrent chest pain episodes in patients with coronary artery disease

• Prophylaxis before physical activity: Reduces the risk of exertional angina attacks

• Adjunct therapy in ischemic heart disease: Used alongside other medications to manage cardiovascular risk

• Long-term management of coronary artery disease: Helps maintain consistent symptom control

This medication is intended for adult patients diagnosed with chronic angina and should be used under the supervision of a physician.

Key Benefits

• Long-acting angina prevention: Provides sustained relief from chest pain over 12–24 hours

• Reduces heart workload: Vasodilation lowers cardiac oxygen demand

• Improves exercise tolerance: Helps patients perform daily activities with fewer angina episodes

• Convenient dosing: Once- or twice-daily regimen enhances compliance

• Predictable and controlled effect: Sustained-release formulation maintains stable blood levels, minimizing fluctuations

Nidocard Retard offers a convenient and effective solution for patients requiring long-term angina prophylaxis while maintaining consistent cardiovascular protection.

Dosage and Administration

• The usual starting dose is 2.6 mg once daily, preferably in the morning; dose adjustments are made based on clinical response and tolerance

• Swallow the tablet whole with water; do not crush, chew, or break the tablet

• Take consistently at the same time each day to maintain steady plasma levels

• Avoid abrupt discontinuation to prevent angina recurrence

• Can be used in combination with other anti-anginal therapies as prescribed by the physician

Dosage must be individualized based on the patient’s condition, response, and concurrent therapies.

Precautions

• Use with caution in patients with hypotension, severe anemia, or increased intracranial pressure

• Avoid concurrent use with phosphodiesterase inhibitors (e.g., sildenafil, tadalafil), as this may cause severe hypotension

• Monitor blood pressure regularly, especially during initial therapy or dose changes

• Pregnancy and breastfeeding should be managed under medical supervision

• Inform the physician about all medications being taken to prevent interactions

Possible Side Effects

Nidocard Retard Tablet 2.6 mg is generally well tolerated. Common side effects include:

• Headache, especially during initial therapy

• Dizziness or lightheadedness

• Flushing or warmth of the face

• Rare: hypotension, fainting, or rapid heartbeat

Most side effects are mild, transient, and often decrease with continued use or dose adjustment.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage Instructions

• Store in a cool, dry place below 25°C, away from light and moisture

• Keep the tablets in their original packaging until use

• Keep out of reach of children

• Do not use after the expiration date

Nidocard Retard Tablet 2.6 mg (Nitroglycerin) provides effective, long-lasting prevention of angina attacks, reducing cardiac stress and improving the quality of life for patients with chronic coronary artery disease.